C Ford

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. ncbi Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
    C Ford
    Department of Neurology and the Clinical and Magnetic Resonance Research Center and Multiple Sclerosis Specialty Clinic, University of New Mexico Health Sciences Center, University of New Mexico School of Medicine, Pete and Nancy Domenici Hall, 1101 Yale Boulevard NE, Albuquerque, NM 87131, USA
    Mult Scler 16:342-50. 2010

Detail Information

Publications1

  1. ncbi Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
    C Ford
    Department of Neurology and the Clinical and Magnetic Resonance Research Center and Multiple Sclerosis Specialty Clinic, University of New Mexico Health Sciences Center, University of New Mexico School of Medicine, Pete and Nancy Domenici Hall, 1101 Yale Boulevard NE, Albuquerque, NM 87131, USA
    Mult Scler 16:342-50. 2010
    ..There were no long-term safety issues...